FDA’s new Amarin decision could change the way drugs are marketed off-label
The Food and Drug Administration just OKed biopharma company Amarin to promote its only drug, Vascepa, for off-label use.
The Food and Drug Administration just OKed biopharma company Amarin to promote its only drug, Vascepa, for off-label use.